Icon

SEROQUEL XR (nda022047)- (EQ 50MG BASE,EQ 200MG BASE,EQ 300MG BASE,EQ 400MG BASE,EQ 150MG BASE)

QUETIAPINE FUMARATE ASTRAZENECA
EQ 50MG BASE,EQ 200MG BASE,EQ 300MG BASE,EQ 400MG BASE,EQ 150MG BASE
Yes No
2017-Nov-28 Expired
None None
None No
SEROQUEL XR is an atypical antipsychotic indicated for the treatment of:  Schizophrenia  Bipolar I disorder, manic, or mixed episodes  Bipolar disorder, depressive episodes  Major depressive disorder, adjunctive therapy with antidepressants.
13 0 9
Total Other Developers 9
Drugs with Suitability No
EQ 50MG BASE ** ** - - 6
EQ 200MG BASE ** ** - - 7
EQ 300MG BASE ** ** - - 7
EQ 400MG BASE ** ** - - 7
EQ 150MG BASE ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** **** ****** ************ ***. *********** * ********* ****, **** ***** ****, *****, *******, ******* ******, ***** (***) ***
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** ******* ******* ************ ******* *********** **** **. ** ** **, ******* ********** ******, *******, ******, *** ******, ***** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** **-**, ****** ** *** ******* ********** ****** ********, *****, ***** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.